Non-alcoholic fatty liver disease (NAFLD) is a non-communicable and a most common form of liver disease, and has strong ties with obesity epidemic. The pathophysiology of Non-alcoholic fatty liver disease (NAFLD) is complex and multifactorial, which makes the diagnosis difficult. On the basis of previous and recent published data, key characters could be proinflammatory cytokines and chemokines that are products of adipose tissue, namely inflammatory cells infiltrating the adipose tissue. In this review we will be discussing the role of adipokines in NAFLD and their interaction with the nutrients in the diet.
| [1] | Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012; 55[6]: 2005-23.View Article PubMed |
| [2] | Hassan K, Bhalla V, Ezz M, Regal E, Hesham H, Hassan A-KK, et al. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World J Gastroenterol. 2014; 20[34]: 12082-101.View Article PubMed PubMed |
| [3] | Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun; 41[6]: 1313-21.View Article PubMed |
| [4] | Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease [NAFLD]. Metabolism. 2016;65[8]:1038-48.View Article PubMed |
| [5] | Alisi A, Cianfarani S, Manco M, Agostoni C, Nobili V. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Ann Med. 2012 Feb; 44[1]: 29-40.View Article PubMed |
| [6] | Sun X, Zemel MB. Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity [Silver Spring]. 2007 Feb; 15[2]: 340-8.View Article PubMed |
| [7] | Polyzos SA, Kountouras J, Mantzoros CS. Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism. 2015 Jan; 64[1]: 60-78.View Article PubMed |
| [8] | Fasshauer M, Blüher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015 Jul; 36[7]: 461-70.View Article PubMed |
| [9] | Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity [Silver Spring]. 2015 Mar; 23[3]: 512-8.View Article PubMed PubMed |
| [10] | Braunersreuther V, Viviani GL, Mach F, Montecucco F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol. 2012 Feb 28; 18[8]: 727-35.View Article PubMed PubMed |
| [11] | Marra F, Bertolani C. Adipokines in Liver Diseases. Hepatology. 2009 Sep; 50[3]: 957-69.View Article PubMed |
| [12] | Polyzos SA, Kountouras J, Mantzoros CS. Adipokines in nonalcoholic fatty liver disease. Metabolism. 2016; 65[8]: 1062-79.View Article PubMed |
| [13] | Wang Z, Nakayama T. Inflammation, a Link between Obesity and Cardiovascular Disease. Mediators Inflamm. 2010; 2010: 17.View Article PubMed PubMed |
| [14] | Havel PJ. Update on Adipocyte Hormones. Diabetes. 2004; 53[Suppl 1]: 143-51.View Article PubMed |
| [15] | Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001 May;86[5]:1930-5.View Article PubMed |
| [16] | Karbowska J, Kochan Z. Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol. 2006 Nov;57 Suppl 6: 103-13. |
| [17] | Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology. 2004 Jan; 145[1]: 367-83.View Article PubMed |
| [18] | Havel PJ, Callahan HS, Swarbrick MM, Weigle DS, Matthys CC, Kratz M. Effect of dietary n–3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr. 2008; 87[2]: 347-53.View Article PubMed PubMed |
| [19] | Kovacova Z, Vitkova M, Kovacikova M, Klimcakova E, Bajzova M, Hnevkovska Z, et al. Secretion of adiponectin multimeric complexes from adipose tissue explants is not modified by very low-calorie diet. 2009 Apr; 160[4]: 585-92.View Article PubMed |
| [20] | G M, Cassader M RF, R G. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease [NAFLD]: A systematic review and meta-analysis of randomised trials. Diabetologia. 2012; 55[4]: 885-904.View Article PubMed |
| [21] | Elias MC, Parise ER, de Carvalho L, Szejnfeld D, Netto JP. Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. Nutrition. 26[11-12]: 1094-9.View Article PubMed |
| [22] | Izadi V, Azadbakht L. Specific dietary patterns and concentrations of adiponectin. J Res Med Sci. 2015 Feb; 20[2]: 178-84. |
| [23] | Fargnoli JL, Fung TT, Olenczuk DM, Chamberland JP, Hu FB, Mantzoros CS. Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses’ Health Study. Am J Clin Nutr. 2008 Nov; 88[5]: 1213-24. |
| [24] | Ye R, Holland WL, Gordillo R, Wang M, Wang QA, Shao M, et al. Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes β-cell regeneration. Elife. 2014; 23[3].View Article PubMed PubMed |
| [25] | Xia JY, Sun K, Hepler C, Ghaben AL, Gupta RK, An YA, et al. Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice HHS Public Access. Diabetologia. 2017; 61[4]: 932-41.View Article PubMed PubMed |
| [26] | Fruebis J, Javorschi S, Ebbets-Reed D, Erickson MRS, Yen FT, Bihain BE, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001; 98[4]: 2005-10.View Article PubMed PubMed |
| [27] | Mostowik M, Gajos G, Zalewski J, Nessler J, Undas A. Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease. Cardiovasc Drugs Ther. 2013; 27[4]: 289-95.View Article PubMed PubMed |
| [28] | Gray B, Steyn F, Davies PSW, Vitetta L. Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. Eur J Clin Nutr. 2013 Dec; 67[12]: 1234-42.View Article PubMed |
| [29] | E. M, M. R, L. F, M. A-J, S. S. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr. 2012; 21[4]: 511-8. |
| [30] | Kondo K, Morino K, Nishio Y, Kondo M, Fuke T, Ugi S, et al. Effects of a fish-based diet on the serum adiponectin concentration in young, non-obese, healthy Japanese subjects. J Atheroscler Thromb. 2010 Jun 30; 17[6]: 628-37.View Article PubMed |
| [31] | Rossi AS, Lombardo YB, Lacorte J-M, Chicco AG, Rouault C, Slama G, et al. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol. 2005 Aug; 289[2]: R486-94.View Article PubMed |
| [32] | Wu JHY, Cahill LE, Mozaffarian D. Effect of fish oil on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism. 2013. p. 98[6]: 2451-9.View Article PubMed PubMed |
| [33] | Neschen S, Morino K, Rg J, Rossbacher C, Pongratz RL, Cline GW, et al. Fish Oil Regulates Adiponectin Secretion by a Peroxisome Proliferator-Activated Receptor-Dependent Mechanism in Mice. 2006; 55[4]: 924-8.View Article PubMed |
| [34] | Astapova O, Leff T. Adiponectin and PPARγ: Cooperative and Interdependent Actions of Two Key Regulators of Metabolism. In: Vitamins and Hormones. Academic Press Inc.; 2012. p. 143-62.View Article PubMed |
| [35] | La Cava A. Leptin in inflammation and autoimmunity. Cytokine. 2017; 98: 51-8.View Article PubMed PubMed |
| [36] | Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet Iii DJ, et al. Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia. J Exp Med •. 1997; 185[1]: 171-5.View Article PubMed |
| [37] | Lee M-J, Fried SK. Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion. Am J Physiol Metab. 2009; 296[6]: E1230-8.View Article PubMed PubMed |
| [38] | Romon M, Lebel P, Velly C, Marecaux N, Fruchart JC, Dallongeville J. Leptin response to carbohydrate or fat meal and association with subsequent satiety and energy intake. Am J Physiol Metab. 1999; 277[5]: E855-61.View Article PubMed |
| [39] | Koutsari C, Karpe F, Humphreys SM, Frayn KN, Hardman AE. Plasma leptin is influenced by diet composition and exercise. Int J Obes Relat Metab Disord. 2003 Aug; 27[8]: 901-6.View Article PubMed |
| [40] | Valtueña S, Pellegrini N, Ardigò D, Del Rio D, Numeroso F, Scazzina F, et al. Dietary glycemic index and liver steatosis. Am J Clin Nutr. 2006 Jul; 84[1]: 136-42; quiz 268-9.View Article PubMed |
| [41] | Bawden S, Stephenson M, Falcone Y, Lingaya M, Ciampi E, Hunter K, et al. Increased liver fat and glycogen stores after consumption of high versus low glycaemic index food: A randomized crossover study. Diabetes Obes Metab. 2017; 19[1]: 70-7.View Article PubMed |
| [42] | Raben A, Astrup A. Leptin is influenced both by predisposition to obesity and diet composition. Int J Obes Relat Metab Disord. 2000 Apr; 24[4]: 450–9.View Article PubMed |
| [43] | Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc. 2000 Aug; 59[3]: 359-71.View Article PubMed |
| [44] | de Castro GS, Calder PC. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clin Nutr. 2018; 37[1]: 37-55.View Article PubMed |
| [45] | Salem N. Introduction to polyunsaturated fatty acids. Backgrounder. 1999; 3[1]: 1-8. |
| [46] | Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 Fatty Acids and Cardiovascular Disease New Recommendations From the American Heart Association. 2003; 23[2]: 151-2.View Article |
| [47] | Moreno-Aliaga M, Alfredo M. Sesion 3: Fatty acids and the immune system. Regulation of adipokine secretion by n-3 fatty acids Portion size estimation View project EVASYON View project. 2010; 69[3]: 324-32.View Article PubMed |
| [48] | Mueller WM, Gregoire FM, Stanhope KL, Mobbs C V, Mizuno TM, Warden CH, et al. Evidence That Glucose Metabolism Regulates Leptin Secretion from Cultured Rat Adipocytes*. 1998; 139[2]: 551-8.View Article PubMed |
| [49] | Mueller WM, Stanhope KL, Gregoire F, Evans JL, Havel PJ. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes. Obes Res. 2000; 8[7]: 530-9.View Article PubMed |
| [50] | Pérez-Matute P, Marti A, Martínez JA, Fernández-Otero MP, Stanhope KL, Havel PJ, et al. Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism. Am J Physiol Regul Integr Comp Physiol. 2005 Jun; 288[6]: R1682-8.View Article PubMed |
| [51] | Ramel A, Martinez JA, Kiely M, Bandarra NM, Thorsdottir I. Effects of weight loss and seafood consumption on inflammation parameters in young, overweight and obese European men and women during 8 weeks of energy restriction. Eur J Clin Nutr. 2010 Sep; 64[9]: 987-93.View Article PubMed |
| [52] | Dahl TB, Holm S, Aukrust P, Halvorsen B. Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology. Annu Rev Nutr. 2012 Aug 21; 32[1]: 229-43.View Article PubMed |
| [53] | WEN Y, WANG H, WU J, LU H, HU X, Katherine C. Effects of fatty acid regulation on visfatin gene expression in adipocytes. Chin Med J [Engl]. 2006 Oct; 119[20]: 1701-8.View Article PubMed |
| [54] | Chang Y-C, Chang T-J, Lee W-J, Chuang L-M. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Metabolism. 2010 Jan; 59[1]: 93-9.View Article PubMed |
| [55] | Pérez-Echarri N, Pérez-Matute P, Marcos-Gómez B, Martínez JA, Moreno-Aliaga MJ. Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight [cafeteria diet-fed] rats. Br J Nutr. 2009 Apr; 101[7]: 1059-67.View Article PubMed |
| [56] | Jamaluddin MS, Weakley SM, Yao Q, Chen C, DeBakey ME. Themed Section: Fat and Vascular Responsiveness Resistin: functional roles and therapeutic considerations for cardiovascular disease Correspondence. 2011; 165[3]: 622-32.View Article PubMed PubMed |
| [57] | Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes Relat Metab Disord. 2004 Jun; 28[6]: 783-9.View Article PubMed |
| [58] | Shen C, Zhao C-YY, Wang W, Wang Y-DD, Sun H, Cao W, et al. The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis. BMC Gastroenterology 2014 p. 1-9.View Article PubMed PubMed |
| [59] | Musso G, Bo S, Cassader M, De Michieli F, Gambino R. Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism. Am J Clin Nutr. 2013; 98[4]: 895-906.View Article PubMed |
